Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer

doi:10.4251/wjgo.v16.i6.2318

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1433)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

HTML

1068

Figures (1-7)

121

Sum=1230

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

114

Sum=141

Jun 15, 2024 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2318-2334
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2318

Full Size Figure Download Figure

Figure 4 Strategies to overcome mutation-based TKI resistance. A: PDB: 5XFF; B: PDB: 4V01; C: PDB: 4R6V; D: PDB: 6JPJ. Created with BioRender.com (see Supplementary material).

Citation: Jiang YK, Li W, Qiu YY, Yue M. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2318-2334
URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2318.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2318